Curated coverage for lecanemab with top developments, timeline context, and connected threads.
Lecanemab and donanemab slow Alzheimer's progression. Here is the specific clinical benefit, the serious side effects, and the brutal economics of treating the world's most feared disease.
EuroBulletin24 Editorial Desk | Linked source